Understanding Voting Rights and Share Capital Dynamics
Exploring Nanobiotix's Voting Rights and Share Capital
In accordance with French Commercial Code regulations, the voting rights and share capital of companies are vital aspects of corporate governance. For investors and stakeholders, understanding these components at Nanobiotix offers critical insights into its operational dynamics.
Key Information about Shares and Voting Rights
As of the latest reporting, Nanobiotix, which has been included in the Euronext Paris and Nasdaq exchanges, holds a prominent position among biotech companies. The number of outstanding shares plays a crucial role in determining shareholders' voting power. For January 31, 2025, the company reported a total of 47,426,851 outstanding shares. This information directly impacts how decisions are made in corporate meetings and reflects the structure of ownership within the company.
Tally of Voting Rights
The theoretical total number of voting rights is calculated by factoring in all shares attached to voting rights, including those where rights may be suspended. As reported, Nanobiotix had a theoretical voting rights total of 49,208,659, whereas the exercisable voting rights stood at 49,186,541. This distinction is vital, as it denotes how many rights shareholders can utilize when participating in governance decisions.
About Nanobiotix
Founded in 2003 and headquartered in Paris, France, Nanobiotix operates at the forefront of biotechnology. The company's commitment to innovative medical solutions is exemplified through its range of patents and technologies, particularly in oncology and central nervous system disorders. With a vision to redefine patient care through groundbreaking techniques, Nanobiotix stands as a beacon of hope for millions affected by challenging health conditions.
Technological Innovations
Nanobiotix is not just a typical biotech company; they own over 25 patent families linked to three distinct nanotechnology platforms. These platforms aim to enhance treatment efficacy in various applications, thereby improving bioavailability and biodistribution of therapeutics. The continuous evolution of these technologies is a critical focus for the company, positioning it for future advancements in patient treatment.
Company Presence and Global Strategy
Nanobiotix's influence extends beyond its Paris headquarters. The company boasts subsidiaries in key markets, including Cambridge, Massachusetts, enhancing its global footprint and access to cutting-edge research. This strategic positioning allows them to collaborate with some of the brightest minds in biotechnology and expand their innovative capabilities.
Connecting with Nanobiotix
Anyone interested in following Nanobiotix's journey can engage with the company through its website or on various social media platforms. The commitment of its teams and the shared vision of making a significant difference for humanity are central to their mission, paving the way for breakthroughs in health treatments.
Frequently Asked Questions
What are the current voting rights at Nanobiotix?
As of January 31, 2025, Nanobiotix reported a total of 49,208,659 theoretical voting rights and 49,186,541 exercisable voting rights.
Why are voting rights important for shareholders?
Voting rights empower shareholders to influence company decisions, allowing them to vote on key aspects such as board elections and corporate policies.
What is unique about Nanobiotix's approach?
Nanobiotix focuses on disruptive, physics-based therapeutic approaches, striving to enhance treatment outcomes in serious medical conditions.
Where is Nanobiotix headquartered?
Nanobiotix is headquartered in Paris, France, and has established a presence in other strategic locations like Cambridge, Massachusetts.
How can I get more information about Nanobiotix?
For more information, visit their official website or follow them on LinkedIn and Twitter to stay updated on their latest advancements and initiatives.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.
